COMPANY
Myris Therapeutics
Funding and NIH signals
- SEC Form D raise Raised $500K (Form D filed Oct 14, 2026). SEC Form D 0001924725-26-000004 (Oct 14, 2026)
Evidence (1 event)
- Oct 14, 2026 · SEC Form D 0001924725-26-000004
Name of Issuer: Myris Therapeutics, Inc.; CIK: 1924725; Address: Sharpsburg, PA; Submission type: D; Filing date: 2026-10-14; Industry Group: Biotechnology; Date of First Sale: 2026-09-01; Types of Securities Offered: Other (Convertible Promissory Notes); Business combination transaction: false; Total Offering Amount: 4500000; Total Amount Sold: 500000; Federal exemptions: 06b
- Oct 14, 2026 · SEC Form D 0001924725-26-000004